Exclusive Summary

• Backed by US-FDA GMP certification and valid product registration in the US market, offering global top-tier quality standards ready for immediate Distribution partnership and commercialization in the US.
• Leverages the US FDA approval as a powerful regulatory credential to fast-track market entry and registration processes in lucrative emerging markets such as LATAM, MENA, and ASEAN.
• Targets a massive and continuous demand from over 4 billion HSV-infected individuals globally, functioning as a WHO Essential Medicine and first-line guideline therapy with highly stable consumption (200mg as standard for recurrent episodes).
• Synergizes premium FDA-compliant quality with exceptional manufacturing cost-effectiveness driven by China's robust API supply chain, securing highly competitive tender pricing and lucrative margins for overseas distributors.